TAEKYUNG CHEMICAL Discloses Corporate Governance Report: Multiple Non-Compliance with Key Indicators Raises Shareholder Rights Concerns
TAEKYUNG CHEMICAL (market cap 84.3B KRW) disclosed its 2025 corporate governance report, failing to comply with 11 out of 15 key indicators, indicating shortcomings in shareholder rights protection and board independence.
A small-scale merger (absorption of TAEKYUNG GREEN CHEMICAL completed in April 2025) was conducted without issuing new shares, causing no dilution for existing shareholders, but opposition shareholders (0.8%) were not granted appraisal rights, lacking minority protection.
Dividend per share remained at 180 KRW (yield 2.2%), stable for three years, but absence of mid-to-long-term shareholder return policy and dividend determination after the record date reduces predictability.
The AGM notice was not sent four weeks in advance (only 19 days), and the meeting date was not avoided on concentrated dates. Electronic voting was implemented but not written voting. The auditor appointment resolution had 25% opposition, reflecting shareholder dissatisfaction.
The board consists of 2 inside directors and 1 outside director, with the outside director's attendance rate at 46.7%. No CEO succession policy or enterprise risk management policy exists, and evaluation/training for outside directors is lacking.
[AI Comprehensive Analysis]TAEKYUNG CHEMICAL's governance structure is at a level requiring improvement as a small-cap listed company. While the no-dilution merger was positive, inadequate shareholder communication/protection and absence of a long-term return policy reduce investment appeal. Future governance enhancements and concrete shareholder return plans could positively impact the stock price.